Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $628.49 | 13 | 79.2% |
| Education | $165.25 | 3 | 20.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $210.25 | 4 | $0 (2021) |
| Janssen Biotech, Inc. | $194.42 | 7 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $120.00 | 1 | $0 (2018) |
| PFIZER INC. | $102.84 | 2 | $0 (2023) |
| GENZYME CORPORATION | $85.83 | 1 | $0 (2017) |
| Biofrontera Inc. | $80.40 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $15.27 | 1 | PFIZER INC. ($15.27) |
| 2021 | $69.50 | 1 | Novartis Pharmaceuticals Corporation ($69.50) |
| 2020 | $61.00 | 1 | Novartis Pharmaceuticals Corporation ($61.00) |
| 2019 | $211.81 | 7 | Janssen Biotech, Inc. ($132.06) |
| 2018 | $200.40 | 2 | Regeneron Healthcare Solutions, Inc. ($120.00) |
| 2017 | $235.76 | 4 | PFIZER INC. ($87.57) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/19/2023 | PFIZER INC. | CIBINQO (Drug) | Education | In-kind items and services | $15.27 | General |
| Category: Inflammation & Immunology | ||||||
| 04/27/2021 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological), COSENTYX | Food and Beverage | In-kind items and services | $69.50 | General |
| Category: IMMUNOLOGY | ||||||
| 01/14/2020 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $61.00 | General |
| Category: IMMUNOLOGY | ||||||
| 05/15/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $66.25 | General |
| Category: DERMATOLOGY | ||||||
| 05/15/2019 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: DERMATOLOGY | ||||||
| 04/02/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $7.60 | General |
| Category: Immunology | ||||||
| 03/27/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 03/27/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $5.00 | General |
| Category: Immunology | ||||||
| 03/06/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $13.46 | General |
| Category: Immunology | ||||||
| 02/19/2019 | Janssen Biotech, Inc. | Tremfya (Drug) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: Immunology | ||||||
| 05/05/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/21/2018 | Biofrontera Inc. | Ameluz (Drug), BF-RhodoLED | Food and Beverage | Cash or cash equivalent | $80.40 | General |
| Category: Dermatology | ||||||
| 10/18/2017 | GENZYME CORPORATION | ATOPIC DERMATITIS - DISEASE (Drug) | Food and Beverage | In-kind items and services | $85.83 | General |
| 09/20/2017 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $87.57 | General |
| Category: DERMATOLOGY | ||||||
| 08/21/2017 | Janssen Biotech, Inc. | STELARA (Biological) | Education | In-kind items and services | $49.99 | General |
| Category: Immunology | ||||||
| 01/25/2017 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,231 | 3,859 | $644,664 | $168,785 |
| 2022 | 22 | 2,351 | 4,136 | $674,028 | $176,962 |
| 2021 | 23 | 2,130 | 3,325 | $600,045 | $161,921 |
| 2020 | 21 | 2,053 | 3,580 | $594,845 | $152,861 |
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 485 | 645 | $149,640 | $37,163 | 24.8% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 55 | 57 | $62,320 | $18,132 | 29.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 411 | 514 | $70,476 | $18,089 | 25.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 205 | 229 | $56,259 | $13,771 | 24.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 154 | 172 | $49,179 | $12,617 | 25.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 129 | 129 | $36,378 | $9,075 | 24.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 105 | $34,650 | $8,522 | 24.6% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 26 | 29 | $27,322 | $7,914 | 29.0% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 19 | 21 | $25,557 | $7,607 | 29.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 294 | 1,559 | $26,503 | $7,011 | 26.5% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 21 | 21 | $16,485 | $4,730 | 28.7% |
| 11602 | Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 38 | 42 | $13,188 | $3,946 | 29.9% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 33 | 36 | $12,816 | $3,849 | 30.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 66 | 66 | $12,144 | $2,824 | 23.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 73 | 79 | $11,376 | $2,714 | 23.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 45 | 67 | $8,978 | $2,524 | 28.1% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 16 | 20 | $7,684 | $2,196 | 28.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 16 | 18 | $7,560 | $2,138 | 28.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $7,225 | $1,540 | 21.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 14 | 15 | $4,965 | $1,236 | 24.9% |
| 11402 | Removal of noncancer skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 18 | $3,960 | $1,186 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 470 | 611 | $141,752 | $34,070 | 24.0% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 418 | 535 | $72,912 | $18,429 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 189 | 207 | $68,310 | $17,935 | 26.3% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 218 | 249 | $61,180 | $16,034 | 26.2% |
About Dr. Chong Wee Foo, M.D
Dr. Chong Wee Foo, M.D is a Dermatology healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2007. The National Provider Identifier (NPI) number assigned to this provider is 1588861058.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chong Wee Foo, M.D has received a total of $793.74 in payments from pharmaceutical and medical device companies, with $15.27 received in 2023. These payments were reported across 16 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($628.49).
As a Medicare-enrolled provider, Foo has provided services to 8,765 Medicare beneficiaries, totaling 14,900 services with total Medicare billing of $660,529. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Eugene, OR
- Active Since 06/28/2007
- Last Updated 05/09/2016
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1588861058
Products in Payments
- COSENTYX (Biological) $210.25
- Tremfya (Drug) $132.06
- DUPIXENT DUPILUMAB INJECTION (Biological) $120.00
- EUCRISA (Drug) $87.57
- ATOPIC DERMATITIS - DISEASE (Drug) $85.83
- Ameluz (Drug) $80.40
- STELARA (Biological) $62.36
- CIBINQO (Drug) $15.27
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Eugene
Dr. Diane Baird, M.d, M.D
Dermatology — Payments: $5,811
Benjamin Vazquez, Md, MD
Dermatology — Payments: $4,974
Troy Richey, Md Pc, MD PC
Dermatology — Payments: $3,246
Gregory Richterich, Md, MD
Dermatology — Payments: $2,626
Dr. Hannibal Eccles, Md, MD
Dermatology — Payments: $1,904
Cynthia Dreyer, M.d, M.D
Dermatology — Payments: $1,081